Yves Allenbach

Also affiliated with Sorbonne Université, Assistance Publique – Hôpitaux de Paris, Institut de Myologie, Pitié-Salpêtrière Hospital, Centre de Recherche en Myologie

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 7 papers. Top paper: “Efficacy and Safety of Bimagrumab in Sporadic Inclusion Body Myositis”.

Efficacy and Safety of Bimagrumab in Sporadic Inclusion Body Myositis

Neurology(2021)10.1212/wnl.0000000000011626

N/A

0DataRank · unranked

37 citations

Michael G. Hanna, Pedro Machado, Umesh A. Badrising, Hector Chinoy, Olivier Benvéniste +93 more

Association of early electrical changes with cardiovascular outcomes in immune checkpoint inhibitor myocarditis

Archives of cardiovascular diseases(2022)10.1016/j.acvd.2022.03.003

N/A

0DataRank · unranked

40 citations

Joachim Alexandre, Arrush Choudhary, Benay Ozbay, Salim S. Hayek, Aarti Asnani +61 more

Discrepancies of cardio-muscular biomarkers in the diagnosis and prognostication of immune checkpoint inhibitor (ICI)-associated myocarditis

Research Square(2022)10.21203/rs.3.rs-2030687/v1

N/A

0DataRank · unranked

1 citations

Markus Heckmann, Guillaume Bailly, Daniel Finke, Frederic Stein, John R. Power +17 more

Abatacept/Ruxolitinib and Screening for Concomitant Respiratory Muscle Failure to Mitigate Fatality of Immune-Checkpoint Inhibitor Myocarditis

Cancer Discovery(2023)10.1158/2159-8290.cd-22-1180

N/A

0DataRank · unranked

208 citations

Marie Bretagne, Baptiste Abbar, Sarah Léonard-Louis, Stéphane Éderhy, Alban Redheuil +38 more

Cardiomuscular Biomarkers in the Diagnosis and Prognostication of Immune Checkpoint Inhibitor Myocarditis

Circulation(2023)10.1161/circulationaha.123.062405

N/A

0DataRank · unranked

147 citations

Markus Heckmann, Guillaume Bailly, Daniel Finke, Adrien Procureur, John R. Power +58 more

Zilucoplan in immune-mediated necrotising myopathy: a phase 2, randomised, double-blind, placebo-controlled, multicentre trial

The Lancet Rheumatology(2023)10.1016/s2665-9913(23)00003-6

N/A

0DataRank · unranked

55 citations

Anthony A. Amato, Mazen M. Dimachkie, Hector Chinoy, Yessar Hussain, James B Lilleker +43 more

273rd ENMC International workshop: Clinico-Sero-morphological classification of the Antisynthetase syndrome. Amsterdam, The Netherlands, 27-29 October 2023

Neuromuscular Disorders(2024)10.1016/j.nmd.2024.104453

N/A

0DataRank · unranked

32 citations

Andrew L. Mammen, Laure Gallay, Marie‐Therese Holzer, Felix Kleefeld, Olivier Benveniste +18 more